Perfil toxicológico dos suicídios no Rio Grande do Sul, Brasil, 2017 a 2019

Franck, Maria Cristina; Monteiro, Maristela; Limberger, Renata Pereira

doi:10.26633/rpsp.2020.28

Cited by 27 publications

(8 citation statements)

References 33 publications

(11 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Pharmacological immunosuppression or HIV/AIDS, particularly with CD4 counts <200, increases the risk of reactivation in patients with chronic T. cruzi infection [30,31]. The overall observed prevalence of reactivation in the absence of prophylactic treatment is 28% in transplant patients and 36-40% in people co-infected with HIV/AIDs [32].…”

Section: Reactivated Chagas Diseasementioning

confidence: 99%

“…CD blood bank testing protocols should be in place with specific technical guidelines, collection protocols, reporting, and counselling and follow-up of positive cases. Special attention should be given to confirming inconclusive results with a combination of tests, given that the estimated prevalence of CD has been reported to be 13.30% in the stratum of donors with inconclusive serology at screening, and up to two falsenegative results have also been reported, depending on the technique used for testing [32,66].…”

Section: Preventing Oral Transmissionmentioning

confidence: 99%

“…Regional guidelines. The most recent regional clinical guideline is the one published by the Pan-American Health Organization/WHO (PAHO/WHO) [32]. This document focuses on evidencebased recommendations for the diagnosis and treatment of CD in adult and paediatric patients.…”

Section: Improving Access To Resources For Clinical Decision Support?mentioning

confidence: 99%

See 2 more Smart Citations

WHF IASC Roadmap on Chagas Disease

et al. 2020

View full text Add to dashboard Cite

Background: Chagas Disease is a neglected tropical disease caused by the protozoan Trypanosoma cruzi, with some of the most serious manifestations affecting the cardiovascular system. It is a chronic, stigmatizing condition, closely associated with poverty and affecting close to 6 million people globally. Although historically the disease was limited to endemic areas of Latin America recent years have seen an increasing global spread. In addition to the morbidity and mortality associated with the disease, the social and economic burdens on individuals and society are substantial. Often called the 'silent killer', Chagas disease is characterized by a long, asymptomatic phase in affected indivi duals. A pproximately 30% then go on develop chronic Chagas cardiomyopathy and other serious cardiac complications such as stroke, rhythm disturbances and severe heart failure. Methods: In a collaboration of the World Hearth Federation (WHF) and the Inter-American S ociety of Cardiology (IASC) a writing group consisting of 20 diverse experts on Chagas disease (CD) was convened. The group provided up to date expert knowledge based on their area of expertise. An extensive review of the literature describing obstacles to diagnosis and treatment Echeverría et al: WHF IASC Roadmap on Chagas Disease Art. 26, page 2 of 31 of CD along with proposed solutions was conducted. A survey was sent to all WHF Members and, using snowball sampling to widen the consultation, to a variety of health care professionals working in the CD global health community. The results were analyzed, open comments were reviewed and consolidated, and the findings were incorporated into this document, thus ensuring a consensus representation. Results: The WHF IASC Roadmap on Chagas Disease offers a comprehensive summary of current knowledge on prevention, diagnosis and management of the disease. In providing an analysis of 'roadblocks' in access to comprehensive care for Chagas disease patients, the document serves as a framework from which strategies for implementation such as national plans can be formulated. Several dimensions are considered in the analysis: healthcare system capabilities, governance, financing, community awareness and advocacy. Conclusion: The WHF IASC Roadmap proposes strategies and evidence-based solutions for healthcare professionals, health authorities and governments to help overcome the barriers to comprehensive care for Chagas disease patients. This roadmap describes an ideal patient care pathway, and explores the roadblocks along the way, offering potential solutions based on available research and examples in practice. It represents a call to action to decision-makers and health care professionals to step up efforts to eradicate Chagas disease.

show abstract

Section: Reactivated Chagas Diseasementioning

confidence: 99%

Section: Preventing Oral Transmissionmentioning

confidence: 99%

See 1 more Smart Citation

WHF IASC Roadmap on Chagas Disease

et al. 2020

View full text Add to dashboard Cite

show abstract

“…The Brazilian Consensus provides recommendations for etiological treatment linked to strength of evidence; treatment of adults in the chronic indeterminate phase is considered a Class IIa recommendation (Evidence Level B). Another important development is the recent publication of clinical guidelines by the Pan American Health Organization 14 .…”

mentioning

confidence: 99%

Clinical Practice Guidelines for Chagas Disease: Recent Developments and Future Needs

Forsyth

Marchiol

Herazo

et al. 2019

Rev. Soc. Bras. Med. Trop.

View full text Add to dashboard Cite

A review by Olivera and colleagues compared five South American clinical practice guidelines for Chagas disease, assessing quality using the Appraisal of Guidelines Research and Evaluation (AGREE II) method 1. The analysis determined the overall quality of the guidelines issued by ministries of health or professional associations prior to 2016, which ranged from low to moderate. The authors noted that these guidelines did not have a strong connection to the best available evidence. grateful to its donors, public and private, who have provided funding for all DNDi activities since its inception in 2003.

show abstract

“…Según la Organización Panamericana de la Salud (OPS) es un conjunto de formularios normativos, gráficos y de ambas formas en los cuales se registran en forma detallada y ordenada las observaciones y hallazgos relacionados con la salud de una persona. Estos registros constituyen la base para la toma de decisiones médicas en el diagnóstico y tratamiento de los problemas de salud y permiten su evaluación (3).…”

Section: Introducción: Estado Actual Del Problemaunclassified

Evaluación estadística de la calidad de la historia clínica en un servicio de clínica médica del Hospital Interzonal General de Agudos Gral. San Martín de La Plata

Riondet¹

View full text Add to dashboard Cite

La evaluación de la calidad de la atención médica es desde hace tiempo una preocupación de muchos autores e instituciones y es indudable que cualquier establecimiento debe esforzarse por elevar la calidad de la atención a sus pacientes. Existe una relación directa entre la calidad de la atención prestada y la calidad de las Historias Clínicas (HC). Desde hace muchos años los médicos y las autoridades de los establecimientos asistenciales han dedicado esfuerzos al ordenamiento de la HC. Se le pide al médico tratante la mejor calidad de ese documento que, es la única forma que hay para analizar la evolución de una enfermedad, además de las ventajas administrativa y médico legales que tiene. Quién lee una HC puede evaluar qué clase de atención recibe el paciente. De ahí que el primer comité que se ha creado en la mayoría de los establecimientos ha sido el que examina las historias clínicas. La gestión de calidad debe ser encarada con criterio de equidad y de justicia. Existe una innumerable variedad de métodos que se emplean para la auditoria. Muchos de estos son correctos, pero deben ser utilizados con rigor científico y ético, dejando de lado otras consideraciones, para tender al mejoramiento de la calidad de atención médica. Hay muchos modelos de historia clínica pero lo fundamental es que esté correctamente elaborada, contenga los datos que realmente son utilizados en el transcurso de la internación y después del egreso, consigne correctamente la atención de enfermería y otros departamentos técnicos, que esté escrita con letra legible y si fuera posible con computadora. A sí elaboradas son útiles y sirven al establecimiento y a los profesionales que en él trabajan, como servirán a la justicia toda vez que sea requerida su intervención. La Historia Clínica es el elemento clave para el ejercicio profesional del personal sanitario, tanto desde el punto de vista asistencial –pues actúa como guía en el manejo clínico del paciente- como desde el investigador y docente, permitiendo el análisis retrospectivo del desempeño de los profesionales sanitarios. La HC se puede definir como un documento donde se recoge la información que procede de la práctica clínica relativa a un enfermo y donde se resumen todos los procesos a que ha sido sometido. Según la Organización Panamericana de la Salud (OPS) es un conjunto de formularios normativos, gráficos y de ambas formas en los cuales se registran en forma detallada y ordenada las observaciones y hallazgos relacionados con la salud de una persona. Estos registros constituyen la base para la toma de decisiones médicas en el diagnóstico y tratamiento de los problemas de salud y permiten su evaluación. A pesar del alto valor que tiene en todos los aspectos (vg. asistencial, sanitario, docente, investigador, jurídico), no existen disposiciones legales sobre la forma en que deben confeccionarse las HC.

show abstract

Perfil toxicológico dos suicídios no Rio Grande do Sul, Brasil, 2017 a 2019

Cited by 27 publications

References 33 publications

WHF IASC Roadmap on Chagas Disease

WHF IASC Roadmap on Chagas Disease

Clinical Practice Guidelines for Chagas Disease: Recent Developments and Future Needs

Evaluación estadística de la calidad de la historia clínica en un servicio de clínica médica del Hospital Interzonal General de Agudos Gral. San Martín de La Plata

Contact Info

Product

Resources

About